Effects of intraperitoneal recombinant interleukin-1 β in intraperitoneal human ovarian cancer xenograft models: comparison with the effects of tumour necrosis factor
- 1 May 1992
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 65 (5) , 661-666
- https://doi.org/10.1038/bjc.1992.141
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Evaluation of circulating tumor necrosis factor‐α in patients with gynecological malignanciesInternational Journal of Cancer, 1991
- Fibrogenic cytokines: the role of immune mediators in the development of scar tissueImmunology Today, 1991
- In situ detection of tumour necrosis factor in human ovarian cancer specimensEuropean Journal of Cancer and Clinical Oncology, 1990
- Cells secreting tumour necrosis factor show enhanced metastasis in nude miceEuropean Journal of Cancer and Clinical Oncology, 1990
- Anti‐tumor effects of interleukin‐2 and interleukin‐1 in mice transplanted with different syngeneic tumorsInternational Journal of Cancer, 1989
- Paradoxical effects of tumour necrosis factor in experimental ovarian cancerInternational Journal of Cancer, 1989
- Cytostatic and tumoricidal activities of tumor necrosis factor-treated neutrophilsImmunology Letters, 1988
- Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1Nature, 1986
- Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.The Journal of Experimental Medicine, 1986
- Human interferon inhibits the growth of established human breast tumours in the nude mouseInternational Journal of Cancer, 1982